Bagsværd, Denmark, 12 February 2021 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

Original post:
Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *